DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Cubist Pharmaceuticals

Cubist Pharmaceuticals

  • Manufacturers with Signed Rebate Agreements February 1 , 2011

    Manufacturers with Signed Rebate Agreements February 1 , 2011

  • Reporter's Handbook

  • Representative Healthcare and Life Sciences M&A Transactions

    Representative Healthcare and Life Sciences M&A Transactions

  • Major Employers of Chemists in the Northeastern Section

    Major Employers of Chemists in the Northeastern Section

  • Oncology Pharmaceutical

    Oncology Pharmaceutical

  • Clinical Research Services

    Clinical Research Services

  • LG4690 Healthcare Life Scien

    LG4690 Healthcare Life Scien

  • Rebateable Manufacturers

    Rebateable Manufacturers

  • United States Securities and Exchange Commission Washington, D.C

    United States Securities and Exchange Commission Washington, D.C

  • Merck & Co., Inc

    Merck & Co., Inc

  • Advanced Sterilization Products Alpharma Pharmaceuticals

    Advanced Sterilization Products Alpharma Pharmaceuticals

  • Oncology Pharmaceutical

    Oncology Pharmaceutical

  • CY 2020 CDER Drug and Biologic Calendar Year Approvals As of December 31, 2020

    CY 2020 CDER Drug and Biologic Calendar Year Approvals As of December 31, 2020

  • Speciality Players Define M&A As Big Pharma Seeks Focus

    Speciality Players Define M&A As Big Pharma Seeks Focus

  • Biopharma Boom Fosters Deal Spree

    Biopharma Boom Fosters Deal Spree

  • Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)

    Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)

  • IN the UNITED STATES DISTRICT COURT for the DISTRICT of DELAWARE CUBIST PHARMACEUTICALS, INC., Plaintiff, HOSPIRA, INC., Defenda

  • MED-Project Participating Drug Companies - King County Washington, March 2020

Top View
  • 02/04/2016 Provider Subsystem Healthcare and Family Services Run Time: 20:10:22 Report Id 2794D051 Page: 01
  • Transactions in Chemicals & Pharmaceuticals
  • 2794D051numericlist May 2015.Xlsx
  • J&J Plans 10 Potential Blockbuster Filings by 2023
  • Proxy Statement 2015 Annual Report Meet Eve
  • Alliance Expertise at the Forefront: Leadership for the Ecosystem
  • Cubist (NASDAQ:CBST) Company Report Please See the Disclaimer at Back of This Report for Important Information
  • 20200915 MED-Project Participant List.Xlsx
  • Drug Interactions
  • Biostatus Winter // 2014
  • 2016 Annual Report June 20, 2017 DEAR SHAREHOLDERS
  • Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash
  • Jazz Pharmaceuticals
  • Rebateable Manufacturers
  • Manufacturer Abbreviations*
  • Equity Research Report – Jazz Pharmaceuticals
  • Schedule 14A Proxy Statement Pursuant to Section 14(A) of the Securities Exchange Act of 1934 (Amendment No
  • TC 1600 Iprs.Xlsx


© 2024 Docslib.org    Feedback